Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
COSMOS Pharmaceutical Corporation 3349
| Cost of capital | no mention mentions it only outside the narrative | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | names a metric 「(2)目標とする経営指標限られた経営資源を最大限に有効活用し、中長期的に総資産経常利益率を維持または向上させることを目標としております」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Target | target without a date 「なお、総資産経常利益率につきましては8.0%となりました」ManagementAnalysisOfFinancialPositionOperatingResultsAndCashFlowsTextBlock | matched by rule |
| Payout | states a numeric policy 「上記の方針に基づき、第44期(2026年5月期)は、1株につき37.5円の中間配当を実施するとともに、1株につき44.5円の期末普通配当を実施した結果、年間配当額は1株につき82円となり、当期の配当性向は20.3%となりました」DividendPolicyTextBlock | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names